申请人:Richardson-Vicks, Inc.
公开号:EP0383481A2
公开(公告)日:1990-08-22
Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a β-aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of a pharmaceutically acceptable oral carrier. Also provided are methods for providing an anesthetic effect in humans or animals which comprises orally administering to said human or animal a safe and effective amount of these pharmaceutical compositions. Also provided is a novel process for the manufacture of anesthetic lozenges containing a β-aminopropiophenone along with saccharin.
所公开的口服麻醉药物组合物包含:(a) 约 0.02% 至约 25% 的药学上可接受的 β-氨基苯丙酮酸盐,如盐酸地氯诺宁;(b) 约 0.02% 至约 20% 的糖精;以及 (c) 约 1% 至约 99% 的药学上可接受的口服载体。还提供了为人类或动物提供麻醉效果的方法,其中包括向所述人类或动物口服安全有效量的这些药物组合物。还提供了一种制造含有β-氨基苯丙酮和糖精的麻醉锭剂的新工艺。